As of November 6, 2026, CVRx, Inc. is a publicly traded company (Nasdaq: CVRX); its largest reported holder is Johnson & Johnson, with 15.4% on Schedule 13G/A of January 12, 2026 (Schedule 13G/A, January 12, 2026).
Is this your company?
About to sign with, pay or invest in CVRx, Inc.? See the free Snapshot first.
Free to see. No signup.
Is CVRx, Inc. a real, registered company?
- CVRx, Inc. files with the SEC under CIK 1235912 (its SEC filings).
- Its shares are listed under the ticker CVRX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Minneapolis, Minnesota, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CVRx, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is John Landry, Chief Financial Officer (Form 8-K filed 2026-09-21). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Chernett Jorey (filed 2026-08-24).
Who are CVRx, Inc.'s owners and officers?
CVRx, Inc.: incorporated in Delaware; business address in Minneapolis, Minnesota; industry Surgical & Medical Instruments & Apparatus (Schedule 13D/A, 2026-10-02).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-02 | Chernett Jorey | 0.62% |
| Schedule 13D, 2026-08-24 | Chernett Jorey | 5.5% |
| Schedule 13G, 2026-08-14 | Chernett Jorey | 5.5% |
| Schedule 13G/A, 2026-01-12 | Johnson & Johnson | 15.4% |
Questions about who owns CVRx, Inc.
Who owns CVRx, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of CVRx, Inc.: Johnson & Johnson (15.4%, Schedule 13G/A, filed 2026-01-12).
When did Johnson & Johnson buy into CVRx, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Johnson & Johnson on this page is the Schedule 13G/A, filed 2026-01-12, reporting 15.4%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on CVRx, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CVRx, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CVRx, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-21 | John Landry | Chief Financial Officer | appointed | |
| Form 8-K, 2026-06-09 | Jared Oasheim | Chief Financial Officer | departed |
Which insiders own CVRx, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Johnson & Johnson, a 10% owner: 4,024,861 shares (14.1% of shares outstanding), held indirectly through By Johnson & Johnson Innovation - JJDC, Inc., on a joint filing (Form 4/A, 2026-01-08).
- Johnson & Johnson Innovation - JJDC, Inc., a 10% owner: 4,024,861 shares (14.1% of shares outstanding), held indirectly through By Johnson & Johnson Innovation - JJDC, Inc., on a joint filing (Form 4/A, 2026-01-08).
- , a director: 1,918,854 shares (6.7% of shares outstanding), 8,720 held directly and 1,910,134 indirectly (Form 4, 2026-06-03).
- , a director: 994,553 shares (3.5% of shares outstanding), 14,370 held directly and 980,183 indirectly (Form 4, 2026-06-03).
- , the chief executive and president: 284,237 shares (1.00% of shares outstanding) (Form 4, 2026-03-03).
Shares outstanding: 28,485,019 as of 2026-10-29, from the company's latest SEC cover page.
How much has CVRx, Inc. raised?
No fundraising or offering filing from CVRx, Inc. is on file with us.
Keep reading
More on CVRx, Inc. and the records around it.
CVRx, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Sep 2026
Companies that share a holder
- JOHNSON & JOHNSON also filed stake reports on 2 other companies: Rallybio Corporation (Apr 2026), Rapport Therapeutics, Inc. (Oct 2025)
- Chernett Jorey also filed stake reports on 16 other companies: WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026), KAZIA THERAPEUTICS LTD (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cvrx